SCHEMBL932513

SCHEMBL932513

COc1c(C)cc(C2(c3cccc(Br)c3)N=C(N)C(SC)=N2)cc1C

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 14/20 0.51
BACE2 Q9Y5Z0 1/20 0.51
KCNH2 Q12809 5/20 0.45
CTSD P07339 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932204 0.86 BACE1 (0.67) BACE1BACE2KCNH2
SCHEMBL932184 0.84 BACE1 (0.48) BACE1BACE2KCNH2CTSD
SCHEMBL932682 0.84 BACE1 (0.53) BACE1BACE2KCNH2CTSD
SCHEMBL932646 0.79 BACE1 (0.46) BACE1KCNH2CTSD
SCHEMBL932202 0.78 BACE1 (0.34) BACE1BACE2CTSD
SCHEMBL932215 0.76 BACE1 (0.41) BACE1BACE2KCNH2CTSD
SCHEMBL931694 0.75 BACE1 (0.73) BACE1BACE2KCNH2CTSD
SCHEMBL947178 0.74 CTSD (0.37) BACE1BACE2CTSD
SCHEMBL932503 0.73 BACE1 (0.67) BACE1BACE2KCNH2CTSD
SCHEMBL932175 0.73 BACE1 (0.51) BACE1BACE2KCNH2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed